Nanomaterials and metal-organic frameworks for biosensing applications of mutations of the emerging viruses

Green synthesis of ZnO-NPs using sugarcane bagasse waste: phytochemical assessment of extract and biological study of nanoparticles

The accumulation of agricultural and industrial residues inevitably contributes to environmental pollution. Thus, several scientific investigations have been conducted to overcome this problem and to add an economic value proposition. Unlike typical sugarcane bagasse applications, this work presents a novel application of sugarcane bagasse waste in a green synthesis approach for forming zinc oxide nanoparticles (ZnO-NPs). This work opens the door to studying the potential of sugarcane bagasse in a green synthesis orientation. Phytochemical assessment of the aqueous extract of sugarcane bagasse waste was conducted by studying total flavonoid content, total phenolic content, and antioxidant assays. ZnO-NPs were synthesized using the aqueous sugarcane bagasse extract (ASCBE) with a 96% yield. To obtain 99.7% pure ZnO-NPs, nanoparticles were calcined at 550 °C to remove any remaining plant extract residues. The purity and yield of the produced and modified ZnO-NPs were studied. The initially produced and modified ZnO-NPs were characterized using XRD, FT-IR, UV, TEM, TGA, and PL and to determine the necessity of the calcination step. A detailed proposed mechanism for the formation of ZnO-NPs mediated by ASCBE was introduced. The ZnO-NPs were studied for their antibacterial, antifungal, and antiviral activities. The ZnO-NPs before calcination were found to exhibit more potent antimicrobial activity against both P. aeruginosa and A. niger compared to the calcined ZnO-NPs. In addition, molecular docking analysis revealed that the ZnO-NPs had the strongest binding affinity towards the P. aeruginosa RhlG/NADP active-site complex and the crystal structure of Actibind, a T2 RNase of A. Niger. ZnO-NPs also showed promising binding interactions with viral targets, including the Herpes simplex virus type II protease and Influenza virus NS1 effector domain. Additionally, environmental and economic studies were achieved to relate the scientific study with daily life applications.

Novel Tannic Acid-Modified Cobalt-Based Metal-Organic Framework: Synthesis, Characterization, and Antimicrobial Activity

Metal-organic frameworks (MOFs) are a class of hybrid inorganic-organic materials with typical porous structures and a unique morphology. Due to their diversity, they are extensively used in a wide range of applications such as environmental, catalysis, biomedicine, etc. In this study, a novel cobalt-based MOF modified with tannic acid (Co-TPA/TA) (TPA: terephthalic acid; TA: tannic acid) as a promising material for antimicrobial agents was synthesized and characterized by X-ray diffraction, Fourier transform infrared spectroscopy, scanning electron microscopy with energy-dispersive X-ray spectroscopy, X-ray photoelectron spectroscopy, inductively coupled plasma-optical emission spectrometry, and thermogravimetric analysis and compared with an as-synthesized cobalt-based framework. Co-TPA/TA demonstrated good antimicrobial efficiency under optimum conditions against yeast Candida albicans ATCC 10231, Gram-negative Escherichia coli ATCC 8739, and Gram-positive Staphylococcus aureus ATCC 6538 with an inhibition zone ranging from 14 to 20 mm. Reduced ATP levels, generation of reactive oxygen species, membrane damage from cobalt ion release, and development of an alkaline microenvironment could all be contributing factors to the possible antimicrobial pathways. The novel framework can be obtained using simple, affordable, and easily accessible commercial ligands and is considered to have the potential to be used as an antimicrobial material in the future.

Trajectory in biological metal-organic frameworks: Biosensing and sustainable strategies-perspectives and challenges

The ligand attribute of biomolecules to form coordination bonds with metal ions led to the discovery of a novel class of materials called biomolecule-associated metal-organic frameworks (Bio-MOFs). These biomolecules coordinate in multiple ways and provide versatile applications. Far-spread bio-ligands include nucleobases, amino acids, peptides, cyclodextrins, saccharides, porphyrins/metalloporphyrin, proteins, etc. Low-toxicity, self-assembly, stability, designable and selectable porous size, the existence of rigid and flexible forms, bio-compatibility, and synergistic interactions between metal ions have led Bio-MOFs to be commercialized in industries such as sensors, food, pharma, and eco-sensing. The rapid growth and commercialization are stunted by absolute bio-compatibility issues, bulk morphology that makes it rigid to alter shape/porosity, longer reaction times, and inadequate research. This review elucidates the structural vitality, biocompatibility issues, and vital sensing applications, including challenges for incorporating bio-ligands into MOF. Critical innovations in Bio-MOFs' applicative spectrum, including sustainable food packaging, biosensing, insulin and phosphoprotein detection, gas sensing, CO2 capture, pesticide carriers, toxicant adsorptions, etc., have been elucidated. Emphasis is placed on biosensing and biomedical applications with biomimetic catalysis and sensitive sensor designing.

Biosensors for waterborne virus detection: Challenges and strategies

Waterborne viruses that can be harmful to human health pose significant challenges globally, affecting health care systems and the economy. Identifying these waterborne pathogens is essential for preventing diseases and protecting public health. However, handling complex samples such as human and wastewater can be challenging due to their dynamic and complex composition and the ultralow concentration of target analytes. This review presents a comprehensive overview of the latest breakthroughs in waterborne virus biosensors. It begins by highlighting several promising strategies that enhance the sensing performance of optical and electrochemical biosensors in human samples. These strategies include optimizing bioreceptor selection, transduction elements, signal amplification, and integrated sensing systems. Furthermore, the insights gained from biosensing waterborne viruses in human samples are applied to improve biosensing in wastewater, with a particular focus on sampling and sample pretreatment due to the dispersion characteristics of waterborne viruses in wastewater. This review suggests that implementing a comprehensive system that integrates the entire waterborne virus detection process with high-accuracy analysis could enhance virus monitoring. These findings provide valuable insights for improving the effectiveness of waterborne virus detection, which could have significant implications for public health and environmental management.

Metal-Organic Framework as a Fluorescent and Colorimetric Dual-Signal Readout Biosensor Platform for the Detection of a Genetic Sequence from the SARS-CoV-2 Genome

The quest for the development of high-accuracy, point-of-care, and cost-effective testing platforms for SARS-CoV-2 infections is ongoing as current diagnostics rely on either assays based on costly yet accurate nucleic acid amplification tests (NAAT) or less selective and less sensitive but rapid and cost-effective antigen tests. As a potential solution, this work presents a fluorescence-based detection platform using a metal-organic framework (MOF) in an effective assay, demonstrating the potential of MOFs to recognize specific targets of the SARS-CoV-2 genome with high accuracy and rapid process turnaround time. As a highlight of this work, positive detection of SARS-CoV-2 is indicated by a visible color change of the MOF probe with ultrahigh detection selectivities down to single-base mismatch nucleotide sequences, thereby providing an alternative avenue for the development of innovative detection methods for diverse viral genomes.

Sensitivity-enhanced nanoplasmonic biosensor using direct immobilization of two engineered nanobodies for SARS-CoV-2 spike receptor-binding domain detection

Sensitive, rapid, and easy-to-implement biosensors are critical in responding to highly contagious and fast-spreading severe acute respiratory syndrome coronavirus (SARS-CoV-2) mutations, enabling early infection screening for appropriate isolation and treatment measures to prevent the spread of the virus. Based on the sensing principle of localized surface plasmon resonance (LSPR) and nanobody immunological techniques, an enhanced sensitivity nanoplasmonic biosensor was developed to quantify the SARS-CoV-2 spike receptor-binding domain (RBD) in serum within 30 min. The lowest concentration in the linear range can be detected down to 0.01 ng/mL by direct immobilization of two engineered nanobodies. Both the sensor fabrication process and immune strategy are facile and inexpensive, with the potential for large-scale application. The designed nanoplasmonic biosensor achieved excellent specificity and sensitivity for SARS-CoV-2 spike RBD, providing a potential option for accurate early screening of the novel coronavirus disease 2019 (COVID-19).

Recent advances of nanotechnology in COVID 19: A critical review and future perspective

The global anxiety and economic crisis causes the deadly pandemic coronavirus disease of 2019 (COVID 19) affect millions of people right now. Subsequently, this life threatened viral disease is caused due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, morbidity and mortality of infected patients are due to cytokines storm syndrome associated with lung injury and multiorgan failure caused by COVID 19. Thereafter, several methodological advances have been approved by WHO and US-FDA for the detection, diagnosis and control of this wide spreadable communicable disease but still facing multi-challenges to control. Herein, we majorly emphasize the current trends and future perspectives of nano-medicinal based approaches for the delivery of anti-COVID 19 therapeutic moieties. Interestingly, Nanoparticles (NPs) loaded with drug molecules or vaccines resemble morphological features of SARS-CoV-2 in their size (60–140 nm) and shape (circular or spherical) that particularly mimics the virus facilitating strong interaction between them. Indeed, the delivery of anti-COVID 19 cargos via a nanoparticle such as Lipidic nanoparticles, Polymeric nanoparticles, Metallic nanoparticles, and Multi-functionalized nanoparticles to overcome the drawbacks of conventional approaches, specifying the site-specific targeting with reduced drug loading and toxicities, exhibit their immense potential. Additionally, nano-technological based drug delivery with their peculiar characteristics of having low immunogenicity, tunable drug release, multidrug delivery, higher selectivity and specificity, higher efficacy and tolerability switch on the novel pathway for the prevention and treatment of COVID 19.

Prostate-Specific Antigen Monitoring Using Nano Zinc(II) Metal-Organic Framework-Based Optical Biosensor

BACKGROUND

The prostate-specific antigen (PSA) is an important cancer biomarker that is commonly utilized in the diagnosis of prostate cancer. The development of a PSA determination technique that is rapid, simple, and inexpensive, in addition to highly accurate, sensitive, and selective, remains a formidable obstacle.

METHODS

In this study, we developed a practical biosensor based on Zn(II) metal-organic framework nanoparticles (Zn-MOFs-NPs). Many spectroscopic and microanalytical tools are used to determine the structure, morphology, and physicochemical properties of the prepared MOF.

RESULTS

According to the results, Zn-MOFs-NPs are sensitive to PSA, selective to an extremely greater extent, and stable in terms of chemical composition. Furthermore, the Zn-MOFs-NPs did not exhibit any interferences from other common analytes that might cause interference. The detection limit for PSA was calculated and was 0.145 fg/mL throughout a wide linear concentration range (0.1 fg/mL-20 pg/mL).

CONCLUSIONS

Zn-MOFs-NPs were successfully used as a growing biosensor for the monitoring and measurement of PSA in biological real samples.